Cargando…
SPDR-2 DEVELOPMENT OF A NOVEL THERAPEUTIC STRATEGY AGAINST MEDULLOBLASTOMA TARGETING MYC
Medulloblastoma (MB) is the most common pediatric malignant brain tumor, with aggressive behavior and central nervous system dissemination. Standard of care for medulloblastoma include surgery, chemotherapy with platinum agent, and craniospinal radiation. If patients survived with these intensive tr...
Autores principales: | Ito, Hiroshi, Nakahara, Yukiko, Namikawa, Hiroki, Masuoka, Jun, Abe, Tatsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719306/ http://dx.doi.org/10.1093/noajnl/vdac167.007 |
Ejemplares similares
-
A Tumor Suppressor Gene, N-myc Downstream-Regulated Gene 1 (NDRG1), in Gliomas and Glioblastomas
por: Nakahara, Yukiko, et al.
Publicado: (2022) -
SPDR-4 SLFN11 RENDERS MEDULLOBLASTOMA SENSITIVE TO DNA DAMAGE CHEMOTHERAPIES
por: Nakata, Satoshi, et al.
Publicado: (2022) -
SPDR-06 PROTEIN DEUBIQUITINATION PATHWAY IS A NOVEL THERAPEUTIC TARGET AGAINST MALIGNANT CNS NON-GERMINOMATOUS GERM CELL TUMORS
por: Tomiyama, Arata, et al.
Publicado: (2019) -
STMO-14 VALIDATION OF SURGICAL METHODS FOR GLIOMA AROUND THE MOTOR CORTEX
por: Nakahara, Yukiko, et al.
Publicado: (2022) -
NI-18 INVASIONS OF WHITE MATTER AS A PROGNOSTIC FACTOR IN LOW GRADE GLIOMAS
por: Nakahara, Yukiko, et al.
Publicado: (2019)